Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-mediated antibody-dependent enhancement of infection

Virology

Volumn 456-457, Issue 1, 2014, Pages 238-246

  Chotiwan, Nunya ^a   Roehrig, John T ^a   Schlesinger, Jacob J ^b   Blair, Carol D ^c   Huang, Claire Y H ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Antibody dependent enhancement; Dengue virus; Envelope protein; Fc RIIA; Virus entry

Indexed keywords

CELL RECEPTOR; FC RECEPTOR IIA; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY DEPENDENT ENHANCEMENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL SURFACE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENGUE; DENGUE VIRUS 2; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BINDING; SEROTYPE; VIRUS CELL INTERACTION; VIRUS ENTRY;

ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS; ENVELOPE PROTEIN; FCΓRIIA; VIRUS ENTRY;

ANTIBODY-DEPENDENT ENHANCEMENT; CELL LINE; DENGUE VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; RECEPTORS, IGG; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84898867392     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.03.031     Document Type: Article

References (43)

1. Balsitis S.J., Williams K.L., Lachica R., Flores D., Kyle J.L., Mehlhop E., Johnson S., Diamond M.S., Beatty P.R., Harris E. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog. 2010, 6(2):e1000790.
2. Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., Drake J.M., Brownstein J.S., Hoen A.G., Sankoh O., Myers M.F., George D.B., Jaenisch T., Wint G.R., Simmons C.P., Scott T.W., Farrar J.J., Hay S.I. The global distribution and burden of dengue. Nature 2013, 496(7446):504-507.
3. Butrapet S., Kinney R.M., Huang C.Y.H. Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMA. J. Virol. Methods 2006, 131(1):1-9.
4. Butrapet S., Childers T., Moss K.J., Erb S.M., Luy B.E., Calvert A.E., Blair C.D., Roehrig J.T., Huang C.Y.H. Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion. Virology 2011, 413(1):118-127.
5. Chen Y., Maguire T., Hileman R.E., Fromm J.R., Esko J.D., Linhardt R.J., Marks R.M. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 1997, 3(8):866-871.
6. Chu J.J., Ng M.L. Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J. Virol. 2004, 78(19):10543-10555.
7. Crill W.D., Roehrig J.T. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 2001, 75(16):7769-7773.
8. Erb S.M., Butrapet S., Moss K.J., Luy B.E., Childers T., Calvert A.E., Silengo S.J., Roehrig J.T., Huang C.Y.H., Blair C.D. Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes. Virology 2010, 406(2):328-335.
9. Flannagan R.S., Jaumouille V., Grinstein S. The cell biology of phagocytosis. Annu. Rev. Pathol. 2012, 7:61-98.
10. Fibriansah G., Ng T.S., Kostyuchenko V.A., Lee J., Lee S., Wang J., Lok S.M. Structural changes in dengue virus when exposed to a temperature of 37 degrees C. J. Virol. 2013, 87(13):7585-7592.
11. Gromowski G.D., Barrett A.D.T. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 2007, 366(2):349-360.
12. Halstead S.B. Observations related to pathogensis of dengue hemorrhagic fever VI. Hypotheses and discussion. Yale. J. Biol. Med. 1970, 42(5):350-362.
13. Halstead S.B. Pathogenesis of dengue: challenges to molecular biology. Science 1988, 239(4839):476-481.
14. Halstead S.B., Lan N.T., Myint T.T., Shwe T.N., Nisalak A., Kalyanarooj S., Nimmannitya S., Soegijanto S., Vaughn D.W., Endy T.P. Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg Infect Dis. 2002, 8(12):1474-1479.
15. Halstead S.B., Mahalingam S., Marovich M.A., Ubol S., Mosser D.M. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis. 2010, 10(10):712-722.
16. Halstead S.B., Nimmannitya S., Cohen S.N. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale. J. Biol. Med. 1970, 42(5):311-328.
17. Halstead S.B., O'Rourke E.J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 1977, 146(1):201-217.
18. Hiramatsu K., Tadano M., Men R., Lai C.-J. Mutational analysis of a neutralization epitope on the Dengue Type 2 Virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Virology 1996, 224(2):437-445.
19. Huang C.Y.H., Butrapet S., Moss K.J., Childers T., Erb S.M., Calvert A.E., Silengo S.J., Kinney R.M., Blair C.D., Roehrig J.T. The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion. Virology 2010, 396(2):305-315.
20. Kinney R.M., Butrapet S., Chang G.-J.J., Tsuchiya K.R., Roehrig J.T., Bhamarapravati N., Gubler D.J. Construction of infectious cDNA clones for Dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 1997, 230(2):300-308.
21. Kliks S.C., Nimmanitya S., Nisalak A., Burke D.S. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 1988, 38(2):411-419.
22. Kontny U., Kurane I., Ennis F.A. Interferon gamma augments Fcγreceptor-mediated dengue virus infection of human monocytic cells. J. Virol. 1988, 62(11):3928-3933.
23. Kouri G.P., Guzman M.G., Bravo J.R., Triana C. Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull World Health Organ. 1989, 67(4):375-380.
24. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E., Jones C.T., Mukhopadhyay S., Chipman P.R., Strauss E.G., Baker T.S., Strauss J.H. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002, 108(5):717-725.
25. Littaua R., Kurane I., Ennis F.A. Human IgG Fc RII mediates antibody dependent enhancement of dengue virus infection. J. Immunol. 1990, 144(8):3183-3186.
26. Mady B.J., Erbe D.V., Kurane I., Fanger M.W., Ennis F.A. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fcγ receptors. J. Immol. 1991, 147(9):3139-3144.
27. Modis Y., Ogata S., Clements D., Harrison S.C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA 2003, 100(12):6986-6991.
28. Modis Y., Ogata S., Clements D., Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004, 427(6972):313-319.
29. Modis Y., Ogata S., Clements D., Harrison S.C. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J. Virol. 2005, 79(2):1223-1231.
30. Navarro-Sanchez E., Altmeyer R., Amara A., Schwartz O., Fieschi F., Virelizier J.L., Arenzana-Seisdedos F., Despres P. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 2003, 4(7):723-728.
31. Pokidysheva E., Zhang Y., Battisti A.J., Bator-Kelly C.M., Chipman P.R., Xiao C., Gregorio G.G., Hendrickson W.A., Kuhn R.J., Rossmann M.G. Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 2006, 124(3):485-493.
32. Porollo A., Meller J. Versatile annotation and publication quality visualization of protein complexes using POLYVIEW-3D. BMC Bioinform. 2007, 8:316.
33. Rey F.A., Heinz F.X., Mandl C., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 1995, 375(6529):291-298.
34. Rodrigo W.W.S.I., Jin X., Blackley S.D., Rose R.C., Schlesinger J.J. Differential Enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human FcγRIA (CD64) or FcγRIIA (CD32). J. Virol. 2006, 80(20):10128-10138.
35. Rodrigo W.W.S.I., Block O.K.T., Lane C., Sukupolvi-Petty S., Goncalvez A.P., Johnson S., Diamond M.S., Lai C.J., Rose R.C., Jin X., Schlesinger J.J. Dengue virus neutralization is modulated by IgG antibody subclass and Fc gamma receptor subtype. Virology 2009, 394(2):175-182.
36. Roehrig J.T., Bolin R.A., Kelly R.G. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 1998, 246(2):317-328.
37. Roehrig J.T., Butrapet S., Liss N.M., Bennett S.L., Luy B.E., Childers T., Boroughs K.L., Stovall J.L., Calvert A.E., Blair C.D., Huang C.Y Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion. Virology 2013, 441(2):114-125.
38. Sabin A.B. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1952, 1(1):30-50.
39. Smit J.M., Moesker B., Rodenhuis-Zybert I., Wilschut J. Flavivirus cell entry and membrane fusion. Viruses 2011, 3(2):160-171.
40. Sukupolvi-Petty S., Austin S.K., Purtha W.E., Oliphant T., Nybakken G.E., Schlesinger J.J., Roehrig J.T., Gromowski G.D., Barrett A.D., Fremont D.H., Diamond M.S. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J. Virol. 2007, 81(23):12816-12826.
41. Ubol S., Phuklia W., Kalayanarooj S., Modhiran N. Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J. Infect. Dis. 2010, 201(6):923-935.
42. van der Schaar H.M., Rust M.J., Chen C., van der Ende-Metselaar H., Wilschut J., Zhuang X., Smit J.M. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog. 2008, 4(12):e1000244.
43. Zhang X., Sheng J., Plevka P., Kuhn R.J., Diamond M.S., Rossmann M.G. Dengue structure differs at the temperatures of its human and mosquito hosts. Proc. Natl. Acad. Sci. USA 2013, 110(17):6795-6799.